Evidence map›Paper›PMID 26616280›Full record

ArticleToxicology in vitro : an international journal published in association with BIBRA2016

Oxidative stress-responsive transcription factor NRF2 is not indispensable for the human hepatic Flavin-containing monooxygenase-3 (FMO3) gene expression in HepG2 cells.

Swetha Rudraiah, Xinsheng Gu, Ronald N Hines, José E Manautou

Open access · greenAbstract read
In one paragraph

Article in Toxicology in vitro : an international journal published in association with BIBRA, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Swetha RudraiahDepartment of Pharmaceutical Sciences, University of Connecticut, Storrs, CT, USA. Electronic address: swetha.rudraiah@uconn.edu.
Xinsheng GuDepartment of Pharmaceutical Sciences, University of Connecticut, Storrs, CT, USA. Electronic address: gu.xinsheng@gmail.com.
Ronald N HinesUS EPA, National Health and Environmental Effects Research Laboratory, Research Triangle Park, NC, USA. Electronic address: hines.ronald@epa.gov.
José E ManautouDepartment of Pharmaceutical Sciences, University of Connecticut, Storrs, CT, USA. Electronic address: jose.manautou@uconn.edu.
University of Connecticut · USEnvironmental Protection Agency · US

Funding

Transporter Expression in Response to HepatotoxicantsR01DK069557 · NIDDK · UNIVERSITY OF CONNECTICUT STORRS · PI MANAUTOU, JOSE E · 2005 to 2013
$2.4M
NIDDK NIH HHS DK069557NIDDK NIH HHS R01 DK069557
6 · The paper itself

Abstract

The flavin-containing monooxygenases (FMOs) are important for the oxidation of a variety of endogenous compounds and xenobiotics. The hepatic expression of FMO3 is highly variable and until recently, it was thought to be uninducible. In this study, human FMO3 gene regulation by the oxidative stress transcription factor, nuclear factor (erythroid-derived 2)-like 2 (NRF2) was examined. Constitutive FMO3 gene expression is repressed in HepG2 cells, thus this cell can be a good model for FMO3 gene regulation studies. Over-expression of NRF2 in HepG2 cells increased NRF2 target gene expression, heme oxygenase-1 (HMOX1) and NAD(P)H: quinone oxidoreductase-1 (NQO1), but did not alter FMO3 gene expression. Co-transfection studies with NRF2 or its cytosolic regulatory protein, Kelch-like ECH-associated protein 1 (KEAP1), expression vectors, along with FMO3 promoter luciferase reporter constructs of various lengths (5kb or 6kb), did not change FMO3 reporter gene activity significantly. Furthermore, treatment with tert-butyl hydroperoxide (tBHP) and tert-butyl hydroquinone (tBHQ) did not alter FMO3 reporter construct activity. In summary, in vitro results suggest that the transcriptional regulation of FMO3 might not involve the NRF2-KEAP1 regulatory pathway.

Indexed as

Gene Expression RegulationGenes, ReporterHep G2 CellsHumansHydroquinonesIntracellular Signaling Peptides and ProteinsKelch-Like ECH-Associated Protein 1Lipid PeroxidationLiverNF-E2-Related Factor 2Oxidative StressOxygenasesReactive Oxygen SpeciesRNA, Messengertert-Butylhydroperoxide2-tert-butylhydroquinonedimethylaniline monooxygenase (N-oxide forming)HydroquinonesIntracellular Signaling Peptides and ProteinsKEAP1 protein, humanKelch-Like ECH-Associated Protein 1NFE2L2 protein, humanNF-E2-Related Factor 2OxygenasesReactive Oxygen SpeciesRNA, Messengertert-ButylhydroperoxideFlavin-containing monoxygenase-3KEAP1NRF2Oxidative stressTert-butyl hydroperoxideTert-butyl hydroquinone

Identifiers

PMID26616280
PMCPMC4695222
OpenAlexW2199218948

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.